Clinical Trial Update: Impact and Cost of a Pharmacist Pneumococcal Vaccination Program With PNEUMOVAX® 23 at an Urban Senior Center [Phase 4]

View source ↗

Summary

Phase 4 study evaluating the impact and cost of a pharmacist-administered pneumococcal vaccination program using PNEUMOVAX 23 at an urban senior center; study c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumococcal Infection Prevention in Older Adults

Drugs mentioned

• Pneumovax 23 (Pneumococcal polysaccharide vaccine 23-valent)

Snippet

Sponsor: Thomas Jefferson University | Conditions: Study is Open to Seniors Age 50 or Older | Phase 4 | Status: COMPLETED | Results posted: 2018-01-03